Correction to: Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC
3 Department of Pathology, Luzerner Kantonsspital, Lucerne, Switzerland.
4 Laboratory of Clinical and Experimental Pathology, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
5 Hospital-integrated Biobank (BB, Hôpital Pasteur, 0033-00025, Nice, France.
6 FHU OncoAge, IHU RespirERA, Hôpital Pasteur, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
7 Complejo Hospitalario de A Coruña, Corunna, Spain.
8 Institut für Pathologie, Klinikum Kassel, Kassel, Germany.
9 Institut de Pathologie et de Génétique, Gosselies, Belgium.
10 Cabinet de Pathologie Cypath, Lyon, France.
11 Bioptická Laboratoř, Pilsen, Czechia.
12 Department of Clinical and Molecular Medicine, Pathology Unit, St. Andrea University Hospital, University of Rome La Sapienza, Rome, Italy.
13 UF de Pathologie, Centre Jean Perrin, INSERM U1240, Clermont-Ferrand, France.
14 Molecular Pathology Group, Department of Pathology, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Madrid, Spain.
15 Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
16 Institute of Pathology, University Erlangen-Nürnberg, Erlangen, Germany.
17 Comprehensive Cancer Center Erlangen EMN, Erlangen, Germany.
18 Bavarian Cancer Research Center (BZKF), Erlangen, Germany.